Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial)

Carrieri, Maria Patrizia; Protopopescu, Camelia; Younossi, Zobair; Vilotitch, Antoine; Fontaine, Hélène; Petrov-Sanchez, Ventzislava; Marcellin, Marc; Carrat, Fabrice; Hézode, Christophe; Bourlière, Marc

Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial)

Authors: Maria Patrizia Carrieri
Camelia Protopopescu
Zobair Younossi
Antoine Vilotitch
Hélène Fontaine
Ventzislava Petrov-Sanchez
Marc Marcellin
Fabrice Carrat
Christophe Hézode
Marc Bourlière
Publication date: 1 October 2017
Publisher: HAL CCSD
Doi

Abstract

International audienceWe aimed to compare health-related quality of life (HRQL) during and after hepatitis C virus (HCV) treatment in patients receiving pegylated-interferon (PEG-IFN)-containing therapy (including boceprevir or telaprevir-ANRS CO20 CUPIC cohort) who subsequently switched to PEG-IFN-free regimens (sofosbuvir + ledipasvir with or without ribavirin [RBV]-SIRIUS trial)

Similar works

Full text

HAL AMU

oai:HAL:hal-01767765v1

Last time updated on 18/04/2018

This paper was published in HAL AMU.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.